bluebird bio, Inc. (BLUE)

bluebird bio Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year	2022	2021	2020	2019	2018
Cash & Equivalents	113.01	161.16	260.63	327.21	402.58
Short-Term Investments	67.32	138.34	419.6	779.25	982.73
Cash & Cash Equivalents	180.33	299.5	680.23	1,106	1,385
Cash Growth	-39.79%	-55.97%	-38.52%	-20.13%	7.38%
Receivables	0	11.39	3.87	12.83	13.93
Inventory	0	0	10.7	0	0
Other Current Assets	19.16	25.63	520.74	32.89	19.76
Total Current Assets	199.49	336.52	1,216	1,152	1,419
Property, Plant & Equipment	291.36	101.24	84.94	337.06	246.62
Long-Term Investments	1.41	97.11	61.45	131.51	506.12
Goodwill and Intangibles	10.51	5.65	10.04	27.45	26.3
Other Long-Term Assets	52.13	53.28	409.29	79.23	44.81
Total Long-Term Assets	355.41	257.28	565.72	575.25	823.85
Total Assets	554.9	593.8	1,781	1,727	2,243
Accounts Payable	25.09	25.88	13.81	43	17.83
Deferred Revenue	1.5	0	0	18.27	34.94
Current Debt	51.16	23.15	9.71	20.18	0
Other Current Liabilities	50.48	103.96	180.07	142.15	93.66
Total Current Liabilities	128.24	152.99	203.59	223.58	146.43
Long-Term Debt	230.23	66.43	55.71	170.81	153.32
Other Long-Term Liabilities	0.09	0.09	166.9	48.04	58.02
Total Long-Term Liabilities	230.32	66.53	222.61	218.85	211.34
Total Liabilities	358.56	219.52	426.2	442.43	357.77
Total Debt	281.39	89.58	65.42	190.99	153.32
Debt Growth	214.11%	36.94%	-65.75%	24.57%	-0.92%
Retained Earnings	-3,986.5	-3,719.93	-2,900.55	-2,281.85	-1,498.81
Comprehensive Income	-4.07	-2.91	-5.51	-1.89	-3.63
Shareholders' Equity	196.34	374.28	1,355	1,285	1,885
Net Cash / Debt	-101.06	209.92	614.81	915.47	1,232
Net Cash / Debt Growth	-	-65.86%	-32.84%	-25.69%	8.51%
Net Cash Per Share	-1.29	3.05	9.89	16.59	23.68
Working Capital	71.25	183.53	1,012	928.59	1,273
Book Value Per Share	2.50	5.43	21.79	23.28	36.23

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).